Drug Shortage Report for TELMISARTAN

Last updated on 2019-06-01 History
Report ID 67078
Drug Identification Number 02390345
Brand name TELMISARTAN
Common or Proper name TELMISARTAN
Company Name SIVEM PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) TELMISARTAN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2018-11-13
Estimated end date 2019-05-29
Actual end date 2019-05-31
Shortage status Resolved
Updated date 2019-06-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2019-06-01 English Compare
v20 2019-05-31 French Compare
v19 2019-05-31 English Compare
v18 2019-05-27 French Compare
v17 2019-05-27 English Compare
v16 2019-05-13 French Compare
v15 2019-05-13 English Compare
v14 2019-04-29 French Compare
v13 2019-04-29 English Compare
v12 2019-04-22 French Compare
v11 2019-04-22 English Compare
v10 2019-03-25 French Compare
v9 2019-03-25 English Compare
v8 2019-03-11 French Compare
v7 2019-03-11 English Compare
v6 2019-02-15 French Compare
v5 2019-02-15 English Compare
v4 2018-12-03 French Compare
v3 2018-12-03 English Compare
v2 2018-11-19 French Compare

Showing 1 to 20 of 21